ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 135 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,400,031 | +13.0% | 1,485,056 | -11.9% | 0.07% | -1.5% |
| Q1 2023 | $13,632,103 | -48.0% | 1,685,056 | +1.3% | 0.07% | -58.1% |
| Q4 2022 | $26,202,881 | -19.2% | 1,663,675 | -19.3% | 0.16% | -22.7% |
| Q3 2022 | $32,439,000 | +12.8% | 2,060,918 | 0.0% | 0.21% | +19.0% |
| Q2 2022 | $28,770,000 | -19.0% | 2,060,918 | 0.0% | 0.17% | -5.9% |
| Q1 2022 | $35,530,000 | +18.7% | 2,060,918 | +0.1% | 0.18% | +18.6% |
| Q4 2021 | $29,932,000 | -15.0% | 2,058,618 | +5.3% | 0.16% | -18.3% |
| Q3 2021 | $35,201,000 | +43.4% | 1,955,605 | +39.8% | 0.19% | +37.4% |
| Q2 2021 | $24,555,000 | +85.3% | 1,398,372 | +165.9% | 0.14% | +67.5% |
| Q1 2021 | $13,252,000 | – | 525,863 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,858,569 | $85,243,000 | 25.08% |
| Sofinnova Management VIII, L.L.C. | 1,539,480 | $45,907,000 | 24.21% |
| EcoR1 Capital, LLC | 673,100 | $20,072,000 | 5.07% |
| Cormorant Asset Management, LP | 800,000 | $23,856,000 | 3.46% |
| Perceptive Advisors | 1,260,847 | $37,598,000 | 2.14% |
| NEXTHERA CAPITAL LP | 111,500 | $3,325,000 | 1.70% |
| Foresite Capital Management III, LLC | 140,000 | $4,175,000 | 1.60% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $5,964,000 | 1.41% |
| Rock Springs Capital Management LP | 675,000 | $20,129,000 | 1.16% |
| CAXTON CORP | 13,263 | $395,000 | 1.13% |